Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome resulting in dysregulation of eicosanoid immune mediators

Benjamin Schwarz, Lokesh Sharma, Lydia Roberts, Xiaohua Peng, Santos Bermejo, Ian Leighton, Arnau Casanovas Massana, Shelli Farhadian, Albert I. Ko, Yale IMPACT Team, Charles S. Dela Cruz, Catharine M. Bosio
doi: https://doi.org/10.1101/2020.07.09.20149849
Benjamin Schwarz
1Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lokesh Sharma
2Section of Pulmonary and Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lydia Roberts
1Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaohua Peng
2Section of Pulmonary and Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Santos Bermejo
2Section of Pulmonary and Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian Leighton
1Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnau Casanovas Massana
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06520
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shelli Farhadian
4Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, 06520
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert I. Ko
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06520
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles S. Dela Cruz
2Section of Pulmonary and Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bosioc{at}niaid.nih.gov Charles.delacruz{at}yale.edu
Catharine M. Bosio
1Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bosioc{at}niaid.nih.gov Charles.delacruz{at}yale.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: July 2020 to August 2025

AbstractFullPdf
Jul 202016160611
Aug 20203200214
Sep 2020166095
Oct 2020130077
Nov 202074043
Dec 202096069
Jan 2021991265
Feb 2021165532
Mar 2021139739
Apr 20211582939
May 2021131234
Jun 2021115434
Jul 202170830
Aug 2021761337
Sep 202164238
Oct 202196140
Nov 202159732
Dec 202150020
Jan 202261725
Feb 202248413
Mar 202240018
Apr 202252328
May 202252332
Jun 202239410
Jul 20223415
Aug 20223158
Sep 202250216
Oct 20224017
Nov 20224045
Dec 202220210
Jan 202340713
Feb 2023571111
Mar 20233274
Apr 202331618
May 202323312
Jun 202318109
Jul 20231164
Aug 202326258
Sep 202323156
Oct 202334347
Nov 202358112
Dec 20231403
Jan 2024983
Feb 20241786
Mar 202430512
Apr 202419113
May 202425119
Jun 20241315
Jul 202419219
Aug 202421415
Sep 20241669
Oct 202418610
Nov 20248116
Dec 20244012
Jan 202518316
Feb 2025264416
Mar 2025334318
Apr 202523714
May 2025221419
Jun 2025371523
Jul 2025301919
Aug 2025425
Back to top
PreviousNext
Posted July 13, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome resulting in dysregulation of eicosanoid immune mediators
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome resulting in dysregulation of eicosanoid immune mediators
Benjamin Schwarz, Lokesh Sharma, Lydia Roberts, Xiaohua Peng, Santos Bermejo, Ian Leighton, Arnau Casanovas Massana, Shelli Farhadian, Albert I. Ko, Yale IMPACT Team, Charles S. Dela Cruz, Catharine M. Bosio
medRxiv 2020.07.09.20149849; doi: https://doi.org/10.1101/2020.07.09.20149849
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome resulting in dysregulation of eicosanoid immune mediators
Benjamin Schwarz, Lokesh Sharma, Lydia Roberts, Xiaohua Peng, Santos Bermejo, Ian Leighton, Arnau Casanovas Massana, Shelli Farhadian, Albert I. Ko, Yale IMPACT Team, Charles S. Dela Cruz, Catharine M. Bosio
medRxiv 2020.07.09.20149849; doi: https://doi.org/10.1101/2020.07.09.20149849

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)